IRIS
CERCHIONE, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.062
EU - Europa 896
NA - Nord America 878
SA - Sud America 193
AF - Africa 41
OC - Oceania 2
Totale 3.072
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 838
SG - Singapore 554
RU - Federazione Russa 460
CN - Cina 253
IT - Italia 162
BR - Brasile 154
VN - Vietnam 103
HK - Hong Kong 91
NL - Olanda 56
DE - Germania 53
GB - Regno Unito 32
FI - Finlandia 30
FR - Francia 27
CI - Costa d'Avorio 26
IE - Irlanda 25
CA - Canada 19
MX - Messico 17
AR - Argentina 15
IN - India 15
SE - Svezia 13
PL - Polonia 9
BD - Bangladesh 8
AT - Austria 6
JP - Giappone 6
UA - Ucraina 6
ZA - Sudafrica 6
EC - Ecuador 5
IQ - Iraq 5
PY - Paraguay 5
TR - Turchia 5
CL - Cile 4
CZ - Repubblica Ceca 4
ES - Italia 4
ID - Indonesia 4
KG - Kirghizistan 3
KR - Corea 3
MA - Marocco 3
UY - Uruguay 3
BE - Belgio 2
CO - Colombia 2
EG - Egitto 2
LT - Lituania 2
PE - Perù 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CM - Camerun 1
CU - Cuba 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LY - Libia 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RS - Serbia 1
TJ - Tagikistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.072
Salva come PNG Salva come JPEG
Città #
Singapore 258
Moscow 128
Chandler 106
Beijing 102
Ashburn 95
Hong Kong 90
Amsterdam 54
Santa Clara 51
Dong Ket 44
Millbury 30
Munich 26
Seattle 24
Des Moines 22
Los Angeles 22
Napoli 22
Naples 21
Ho Chi Minh City 20
São Paulo 20
Princeton 18
Hefei 17
Buffalo 16
Dallas 15
Nanjing 15
Boston 12
Turku 12
Mexico City 10
Poplar 10
Redondo Beach 10
Hanoi 9
Lawrence 9
London 9
New York 9
Ottawa 9
Helsinki 8
Brooklyn 7
Denver 6
Falkenstein 6
Norwalk 6
Rio de Janeiro 6
Warsaw 6
Atlanta 5
Brasília 5
Changsha 5
Dublin 5
Düsseldorf 5
Frankfurt am Main 5
Marcianise 5
Milan 5
Tokyo 5
Wilmington 5
Chicago 4
Gesualdo 4
Johannesburg 4
Luzzano 4
Montreal 4
Nanchang 4
Orem 4
Phoenix 4
Rome 4
Roubaix 4
San Francisco 4
The Dalles 4
Tianjin 4
Toronto 4
Vitória da Conquista 4
Belo Horizonte 3
Bắc Ninh 3
Charlotte 3
Da Nang 3
Formosa 3
Guangzhou 3
Houston 3
Jiaxing 3
Kunming 3
Lauterbourg 3
Nocera Inferiore 3
Pelotas 3
Petrópolis 3
Pune 3
Redwood City 3
Seoul 3
Shenyang 3
Stockholm 3
Volta Redonda 3
Amparo 2
Baghdad 2
Basra 2
Birigui 2
Bishkek 2
Biên Hòa 2
Brussels 2
Campinas 2
Caracas 2
Chennai 2
Columbus 2
Cuenca 2
Curitiba 2
Divinópolis 2
Florianópolis 2
Fortaleza 2
Totale 1.559
Salva come PNG Salva come JPEG
Nome #
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison 146
RISPOSTA EMATOLOGICA AL TRATTAMENTO CON LENALIDOMIDE IN UNA PAZIENTE AFFETTA DA TROMBOCITEMIA ESSENZIALE JAK2 V617F-POSITIVA E SINDROME MIELODISPLASTICA ASSOCIATA A DEL(5Q) 136
Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma 127
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience 126
Secondary syphilis mimicking malignancy: A case report and review of literature 123
Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1,3-β-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography 122
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 119
Myeloma and other monoclonal gammopathies - Clinical SINONASAL EXTRAMEDULLARY PLASMACYTOMA: PROPOSAL OF PROTOCOL OF FOLLOW-UP 114
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma 112
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 112
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support 111
Safety and comfort of domestic bortezomib injection in real-life experience 109
Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: A real-life experience 107
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 107
Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience 106
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial 102
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone 101
Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease 100
A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide 99
Is anticoagulation with novel oral anticoagulants an effective treatment for tuberculosis patients not achieving a therapeutic range with vitamin k antagonists? A Systematic Review 98
Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia 97
Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma 93
Correspondence in reference to previously published manuscript: "Faouzi Djebbari et al. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma. Eur J Haematol 2020; 105: 667-671." 90
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis 88
Vitiligo-like lesions in an adult patient treated with Imatinib mesylate 87
Reply to the letter to the editor "chronic disseminated candidiasis" by Kenneth Rolston 86
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report 85
Randomized Comparison of Power Doppler Ultrasonography-Guided Core-Needle Biopsy with Open Surgical Biopsy for the Characterization of Lymphadenopathies in Patients with Suspected Lymphoma, 83
Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art 71
KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patients 58
MM-499 Pegfilgrastim Versus Filgrastim in the Supportive Care of Heavily Pretreated Multiple Myeloma in Treatment With Pomalidomide-Dexamethasone 39
MDS-502 Supportive Care in Low-Risk Myelodysplastic Syndromes: Role of Erythropoiesis Stimulating Agents (ESAs) 24
MM-498 Addition of Carfilzomib as a Third Agent in Lenalidomide-Refractory Multiple Myeloma: Switching From Doublet to Triplet 7
null 1
null 1
Totale 3.187
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 8 0 7 0 3 0 47
2021/2022198 0 0 0 0 1 10 5 5 21 17 77 62
2022/2023278 27 14 14 10 37 27 2 32 45 52 15 3
2023/2024178 8 25 14 8 17 17 1 47 2 3 27 9
2024/2025980 28 17 0 10 41 69 92 74 65 105 385 94
2025/20261.167 196 139 217 157 405 53 0 0 0 0 0 0
Totale 3.187